- A key acquisition brought in the Skaergaard project, a palladium, gold and platinum deposit in southeast Greenland now held through the company’s subsidiary Major Precious Greenland A/S.
- Additional acquisitions, including a rare earths asset, represent the company’s focus on becoming a significant player in the mining space.
A company can rarely reinvent itself overnight, but Greenland Mines (NASDAQ: GRML), has come close. What started the year as a biotech firm has become a two-division mining company in the span of a few months, and its acquisition activity since then shows no sign of slowing.
Previously known as Klotho Neurosciences Inc., the company traded under the ticker KLTO. In March 2026, however, the company announced two significant changes: a name change to Greenland Mines Ltd and a NASDAQ ticker switch to GRML. In addition, the announcement noted a strategic acquisition that shifted the company’s core focus. The filing was announced through an 8-K with the Securities and Exchange Commission, along with an investor webcast explaining the move to shareholders.
That acquisition brought in the Skaergaard project, a palladium, gold and platinum deposit in southeast Greenland now held through the company’s subsidiary Major Precious Greenland A/S. Since March, the company has continued building momentum. Last month, Greenland reported an updated mineral resource estimate under the SEC’s S-K 1300 standard, raising indicated palladium equivalent metal by 31% to 15.0 million ounces and lifting the indicated grade by 36% to 3.04 grams per tonne.
Earlier, in May, the company signed a definitive agreement to acquire the Sarfartoq neodymium-praseodymium rare earths project from Neo Performance Materials for $35 million, split between $20 million in cash and $15 million in company stock. Sarfartoq’s historic resource includes an estimated 27 million kilograms of neodymium oxide and 8 million kilograms of praseodymium oxide, elements used in the permanent magnets that power electric vehicles and wind turbines.
Neo Performance Materials is staying involved rather than exiting. The company is retaining an equity stake in Greenland Mines along with offtake rights covering up to 60% of Sarfartoq’s future production once the acquisition closes, effectively lining up a buyer before the project reaches production. Closing remains subject to approval from the Greenland government under the country’s Mineral Activities Act.
The company added a third leg to its strategy in June 2026 through a share exchange agreement with AnorTech Inc., a company trading on the TSX Venture Exchange. Greenland Mines agreed to acquire a 9.9% equity stake in AnorTech for roughly C$5 million, paid in newly issued Greenland Mines shares, with an option to increase its position to as much as 19.9% during the following six months. The deal gives Greenland Mines exposure to sustainable and high-purity alumina production, adding a processing layer above its upstream mining assets.
Notably, the company has not abandoned its biotech roots. Its cell and gene therapy division continues to advance KLTO-202, targeting amyotrophic lateral sclerosis, along with KLTO-101, aimed at Alzheimer’s disease, and additional therapies for Parkinson’s and other age-related disorders. That keeps Greenland Mines as a company with exposure to both natural resources and biotechnology under one publicly traded structure, an unusual combination for a NASDAQ-listed exploration company.
Taken together, the moves since March 2026 show a company moving quickly to build out a broader platform. A name change and ticker switch brought in a flagship precious metals project, a resource upgrade strengthened that project’s regulatory standing, a rare earths acquisition added a second critical mineral exposure with a committed offtake partner and an equity investment added downstream materials optionality.
For more information, visit www.GreenlandMines.com.
NOTE TO INVESTORS: The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML
About MissionIR
MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.
MIR is where breaking news, insightful content and actionable information converge.
For more information, please visit www.MissionIR.com
Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer
MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com
MissionIR is powered by IBN